Skip to main content

Eli Lilly Launches Digital Pharmacy With Home Delivery Service

Published: 1/8/24 6:49 pm
By Anna Brooks

LillyDirect, a new telehealth platform and online pharmacy, aims to improve access to resources and medication for people living with diabetes, obesity, and migraines.

Pharmaceutical company Eli Lilly is expanding its healthcare offerings with a new digital service, LillyDirect.

Through LillyDirect, which launched in January 2024, people can connect with independent healthcare providers and get prescriptions filled online via a digital pharmacy.

The service also offers direct home delivery free of charge for certain medications including Lilly’s Zepbound (tirzepatide), a weight loss medication approved by the FDA in November 2023.

To provide people with easier access to prescriptions and in-person or remote care, Lilly is partnering with the following telehealth platforms: 

  • 9amHealth, a virtual diabetes clinic

  • Forum, an online weight loss clinic for those living with overweight or obesity

  • Cove, an online medical center for migraines

While all three partner organizations can prescribe any type of medication, only those available through LillyDirect Pharmacy Solutions are eligible for free home delivery. Drug discounts are also available for people who qualify for Lilly’s savings card programs.

Not all Lilly medications are offered through its digital pharmacy (notably, Mounjaro, Lilly’s other tirzepatide drug used to treat type 2 diabetes, is not currently offered), but here are the ones available so far.

For diabetes:

  • Basaglar (insulin glargine)

  • Rezvoglar (insulin glargine)

  • Humalog (insulin lispro)

  • Lyumjev (insulin lispro)

  • Humulin N (intermediate-acting insulin)

  • Humulin R (short-acting insulin)

  • Humulin 70/30 (premixed insulin)

For weight loss:

  • Zepbound (tirzepatide)

For migraine:

  • Emgality (galcanezumab)

While other companies like WeightWatchers and Ro specialize in prescribing and delivering weight loss drugs and other medications, Lilly is in a unique position as a pharmaceutical company now making drugs it develops (like Zepbound) available.

It’s yet to be seen what cost-savings will look like for consumers, especially for medications in short supply like tirzepatide and semaglutide. Without insurance or discount cards, drugs like Zepound, for example, cost upwards of $1,000 per month.

Read more about diabetes drugs and cost-savings programs here:

What do you think?

About the authors

Anna Brooks is a Managing Editor at diaTribe. She has a master’s degree in journalism with a specialization in health and science. Originally from Calgary, Anna has worked as a... Read the full bio »